Global Cord Blood Co. (NYSE:CO - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.93 and traded as high as $0.9505. Global Cord Blood shares last traded at $0.9505, with a volume of 774 shares changing hands.
Global Cord Blood Price Performance
The company's 50 day simple moving average is $0.96 and its 200 day simple moving average is $0.93. The stock has a market cap of $115.53 million, a P/E ratio of 1.49 and a beta of 0.16.
About Global Cord Blood
(
Get Free Report)
Global Cord Blood Corporation NYSE: CO is a leading operator of umbilical cord blood banking services in the People's Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.
In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
